Prevention and treatment of sub-clinical PCVD

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07943298

ABSTRACT:
The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.

REFERENCES:
patent: 5322774 (1994-06-01), Peakman
patent: 5565205 (1996-10-01), Petersen
patent: 5580557 (1996-12-01), Kramer
patent: 5733555 (1998-03-01), Chu
patent: 5885823 (1999-03-01), Knittel
patent: 5925359 (1999-07-01), Van Woensel
patent: 5968525 (1999-10-01), Fitzgerald
patent: 6217883 (2001-04-01), Allan
patent: 6287856 (2001-09-01), Poet
patent: 6294176 (2001-09-01), Cochran
patent: 6368601 (2002-04-01), Allan
patent: 6391314 (2002-05-01), Allan
patent: 6497883 (2002-12-01), Bublot
patent: 6517843 (2003-02-01), Ellis et al.
patent: 6660272 (2003-12-01), Allan
patent: 6703023 (2004-03-01), Jestin et al.
patent: 6794163 (2004-09-01), Liu
patent: 6841364 (2005-01-01), Yuan
patent: 6846477 (2005-01-01), Keich
patent: 6943152 (2005-09-01), Audonnet
patent: 6953581 (2005-10-01), Allan
patent: 7018638 (2006-03-01), Chu
patent: 7109025 (2006-09-01), Eloit
patent: 7122192 (2006-10-01), Allan
patent: 7144698 (2006-12-01), Wang
patent: 7148015 (2006-12-01), Jestin
patent: 7169394 (2007-01-01), Chu
patent: 7172899 (2007-02-01), Liu
patent: 7179472 (2007-02-01), Jestin
patent: 7192594 (2007-03-01), Haines
patent: 7211379 (2007-05-01), Ellis
patent: 7223207 (2007-05-01), Basyuk
patent: 7223407 (2007-05-01), Jestin et al.
patent: 7223594 (2007-05-01), Jestin
patent: 7244433 (2007-07-01), Jestin
patent: 7258865 (2007-08-01), Jestin
patent: 7261898 (2007-08-01), Jestin
patent: 7273617 (2007-09-01), Yuan
patent: 7276353 (2007-10-01), Meng
patent: 7279166 (2007-10-01), Meng
patent: 7297537 (2007-11-01), Jestin
patent: 7300785 (2007-11-01), Meerts
patent: 7314628 (2008-01-01), Jestin
patent: 7323330 (2008-01-01), Jestin
patent: 7335362 (2008-02-01), Karumanchi et al.
patent: 7358075 (2008-04-01), Allibert
patent: 7368117 (2008-05-01), Fetzer
patent: 7371395 (2008-05-01), Parisot
patent: 7390494 (2008-06-01), Jestin
patent: 7405075 (2008-07-01), Jestin
patent: 7407803 (2008-08-01), Jestin
patent: 7425444 (2008-09-01), Jestin
patent: 2003/0170270 (2003-09-01), Meng
patent: 2004/0062775 (2004-04-01), Jestin
patent: 2004/0076635 (2004-04-01), Jestin
patent: 2004/0091502 (2004-05-01), Jestin
patent: 2004/0132178 (2004-07-01), Haines
patent: 2004/0161410 (2004-08-01), Jestin
patent: 2004/0253270 (2004-12-01), Meng
patent: 2004/0265848 (2004-12-01), Jestin
patent: 2005/0008651 (2005-01-01), Jestin
patent: 2005/0058653 (2005-03-01), Ellis
patent: 2005/0079185 (2005-04-01), Parisot
patent: 2005/0084497 (2005-04-01), Jestin
patent: 2006/0002952 (2006-01-01), Haines
patent: 2006/0029617 (2006-02-01), Charreyre
patent: 2006/0115489 (2006-06-01), Birkett
patent: 2006/0204522 (2006-09-01), Kroll
patent: 2006/0222659 (2006-10-01), Jestin
patent: 2006/0233831 (2006-10-01), Parisot
patent: 2006/0286123 (2006-12-01), Fetzer
patent: 2008/0181910 (2008-07-01), Roof
patent: 2008/0233147 (2008-09-01), Jestin
patent: 2008/0261887 (2008-10-01), Roof
patent: 2008/0279875 (2008-11-01), Roof
patent: 2008/0279876 (2008-11-01), Roof
patent: 2008/0279889 (2008-11-01), Roof
patent: 1281760 (2003-02-01), None
patent: 1386617 (2004-02-01), None
patent: 89/06972 (1989-08-01), None
patent: 90/07935 (1990-07-01), None
patent: 91/18627 (1991-12-01), None
patent: 92/03157 (1992-03-01), None
patent: 93/16726 (1993-09-01), None
patent: 95/30437 (1995-11-01), None
patent: 99/18214 (1999-04-01), None
patent: 99/29717 (1999-06-01), None
patent: 99/29871 (1999-06-01), None
patent: 00/47756 (2000-08-01), None
patent: 00/77188 (2000-12-01), None
patent: 01/16330 (2001-03-01), None
patent: 01/17550 (2001-03-01), None
patent: 01/17551 (2001-03-01), None
patent: 01/17556 (2001-03-01), None
patent: 02/49666 (2002-06-01), None
patent: 03/003941 (2003-01-01), None
patent: 2004/058142 (2004-07-01), None
patent: 2004/069184 (2004-08-01), None
patent: 2005/009462 (2005-02-01), None
patent: 2006/072065 (2006-07-01), None
patent: 2006/113372 (2006-10-01), None
patent: 2006/113373 (2006-10-01), None
patent: 2007/028823 (2007-03-01), None
patent: 2007/076520 (2007-07-01), None
Albina et al., An Experimental Model for Post-weaning Multisystemic Wasting Syndrome (PMWS) in Growing Piglets, J. Comp. Path., 2001, vol. 123, 292-303.
Allan et al., Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication, Arch. Virol., 2000, 145: 2421-2429.
Allan et al., Porcine circoviruses: a review, J. Vet. Diagn. Invest., 2000, 12:3-14.
Allan et al., Reproduction of postweaning multisystemic wasting syndrome in pigs experimentally inoculated with a Swedish porcine circovirus 2 isolate, 2003, 15:553-560.
Bassaganya-Riera et al., Conjugated Linoleic Acid Ameliorates Viral Infectivity in a Pig Model of Virally Induced Immunosuppression, American Society for Nutritional Sciences, 2003, 3204-3214.
Blanchard et al., Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins, Vaccine 21, 2003, 4565-4575.
Boisseson et al., Molecular characterization of Porcine circovirus type 2 isolates from post-weaning multisystemic wasting syndrome-affected and non-affected pigs, J Gen Virol, 2004, 85, 293-304.
Bolin et al., Postweaning multisystemic wasting syndrome induced after experimental inoculation of cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus, J Vet Diagn Invest, 2001, 13:185-194.
Chae, C., Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology, The Veterinary Journal, 2004, 168:41-49.
Cheung et al., Kinetics of porcine circovirus type 2 replication, Arch Virol, 2002, 147:43-58.
Darwich et al., Cytokine profiles of peripheral blood mononuclear cells from pigs with postweaning multisystemic wasting syndrome in response to mitogen, superantigen or recall viral antigens, J Gen Virol, 2003, 84, 3453-3457.
Fenaux et al., A Chimeric Porcine Circovirus (PCV) with the Immunogenic Capsid Gene of the Pathogenic PCV Type 2 (PCV2) Clones into the Genomic Backbone of the Nonpathogenic PCV1 Induces Protective Immunity against PCV2 Infection in Pigs, J Virol, Jun. 2004, vol. 78, No. 12, 6297-6303.
GenBank Accession No. AAC61738, Version AAC61738.1 Gl:3661517, Sep. 29, 1998.
Allan et al., Guest Editorial, PCV-2 infection in swine; more than just postweaning multisystemic wasting syndrome, The Veterinary Journal, 2003, 166:222-223.
Inumaru et al., Expression of biologically active recombinant porcine GM-CSF by baculovirus gene expression system, Immunology and Cell Biology, 1998, 76:195-201.
Ju et al., Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2, Veterinary Microbiology, 2005, 109:179-190.
Kim et al., Association of porcine circovirus 2 with porcine respiratory disease complex, The Veterinary Journal, 2003, 166:251-256.
Kim et al., Enteritis associated with porcine circovirus 2 in pigs, The Canadian Journal of Veterinary Research, 2004, 68:218-221.
Kim et al., A Comparison of the Lymphocyte Subpopulations of Pigs Experimentally Infected with Porcine Circovirus 2 and/or Parvovirus, The Veterinary Journal, 2003, 165:325-329.
Kim et al., Characterization of the Recombinant Proteins of Porcine Circovirus Type2 Field Isolate Expressed in the Baculovirus System, J Vet Sci, 2002, 3(1), 19-23.
Kyriakis et al., The Effects of Immuno-modulation of the Clinical and Pathological Expression of Postweaning Multisystemic Wasting Syndrome, J Comp Path, 2002, 126:38-46.
Ladekjaer-Mikkelsen et al., Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2), Veterinary Microbiology, 2002, 89:97-114.
Allan et al., Letters, Immunostimulations, PCV-2 and PMWS, The Veterinary Record, Aug. 5, 2000, 170-171.
Liu et al., Bacterial Expression of an I

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Prevention and treatment of sub-clinical PCVD does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention and treatment of sub-clinical PCVD, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of sub-clinical PCVD will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2667087

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.